APA (7th ed.) Citation

Macilwraith, P., Shackleton, M., Haydon, A., Nadebaum, D., Mar, V., Naranbhai, V., & Cherk, M. H. (2026). Incidence of Reported Pseudoprogression on 18F‐FDG PET/CT in Metastatic Melanoma Patients Undergoing Immune Checkpoint Inhibitor Immunotherapy. Journal of Medical Imaging & Radiation Oncology, 70(2), 162. https://doi.org/10.1111/1754-9485.70066

Chicago Style (17th ed.) Citation

Macilwraith, Philip, Mark Shackleton, Andrew Haydon, David Nadebaum, Victoria Mar, Vivek Naranbhai, and Martin H. Cherk. "Incidence of Reported Pseudoprogression on 18F‐FDG PET/CT in Metastatic Melanoma Patients Undergoing Immune Checkpoint Inhibitor Immunotherapy." Journal of Medical Imaging & Radiation Oncology 70, no. 2 (2026): 162. https://doi.org/10.1111/1754-9485.70066.

MLA (9th ed.) Citation

Macilwraith, Philip, et al. "Incidence of Reported Pseudoprogression on 18F‐FDG PET/CT in Metastatic Melanoma Patients Undergoing Immune Checkpoint Inhibitor Immunotherapy." Journal of Medical Imaging & Radiation Oncology, vol. 70, no. 2, 2026, p. 162, https://doi.org/10.1111/1754-9485.70066.